Articles

Find an Article

Filter articles

Showing 31 to 40 of 695 results

CRISPR: A licence to heal

US01-10-2019Rory O'Neill

As all sides prepare for a milestone case in the battle over rights to CRISPR/Cas9, LSIPR’s Rory O’Neill finds the CEO of ERS Genomics in a positive mood.

Brexit: The waiting game

UK01-10-2019Saman Javed

As lawyers and industry prepare for a possible no-deal Brexit, the uncertainty surrounding its impact is palpable, as LSIPR’s Saman Javed discovers.

M&A: Year of the megadeal

UK, US30-09-2019

LSIPR’s Sarah Morgan investigates the current state of play of M&A in the sector and predicts the next year of activity.

IP portfolios: the five biggest headaches for in-house counsel

International30-09-2019

In-house counsel face daily challenges when managing and maintaining their IP portfolios. LSIPR asked two in-house counsel for the biggest challenges they face when managing and maintaining their IP portfolios. Here are the five things we learned.

Pharma: A Mexican tradeoff

Mexico30-09-2019Margarita Guerrero Gonzalez

While providing benefits to Mexico’s biologics system, the USMCA may also increase costs for citizens, argues Margarita Guerrero Gonzalez of Uhthoff, Gomez Vega & Uhthoff.

Genetic research: DNA payday

International30-09-2019Rory O'Neill

A tie-up between four leading pharmaceutical companies, the UK government and a health charity has created the world’s largest genetic research project. LSIPR’s Rory O’Neill looks at a new frontier for life sciences.

Secondary patents: Moscow mewl

Russia30-09-2019Maxim Sobolev

An intervention by Russia’s IP ombudsman seeks to solve the validity issue over secondary patents, but is it needed, asks Maxim Sobolev of Rouse.

CRISPR: Hearing all about it

UK30-09-2019Catherine Coombes and Emma Longland

There is no doubting the importance of next year’s CRISPR appeal, but any conclusions about the parties’ prior art have consequences for elsewhere too, say Catherine Coombes and Emma Longland of HGF.

Dosage patents: Down the hatch

UK30-09-2019Richard Wells and Stephanie Pilkington

The Actavis v ICOS UK Supreme Court judgment was a bitter pill to swallow, but is it really the end of dosage patents? Richard Wells and Stephanie Pilkington of Potter Clarkson review the situation.

Divisional applications: Procedural manoeuvres pay off

Brazil30-09-2019Kene Gallois and Luis Felipe Maciel da Silva

Filing a divisional patent application in Brazil needs a keen understanding of the process and flexibility in the system, as Kene Gallois and Luis Felipe Maciel da Silva of Daniel Law explain.

Showing 31 to 40 of 695 results

LSIPR